Novavax reported $11.46M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Adma Biologics USD 222.1M 15.63M Mar/2026
AstraZeneca USD 6.93B 362M Jun/2026
BioCryst Pharmaceuticals USD 5.98M 587K Mar/2026
Geron USD 133.29M 16.65M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
MannKind USD 49.17M 13.85M Mar/2026
Merck USD 6.48B 179M Mar/2026
Moderna USD 280M 134M Jun/2026
Novartis USD 6.29B 135M Mar/2026
Novavax USD 11.46M 87K Mar/2026
Pfizer USD 9.94B 722M Jun/2026
Sanofi EUR 24.12B 620M Jun/2026
Sarepta Therapeutics USD 1B 86.37M Mar/2026
TG Therapeutics USD 129.03M 3.44M Mar/2026